Bruker (BRKR) Equity Average (2011 - 2026)

Bruker (BRKR) has 16 years of Equity Average data on file, last reported at $2.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 36.1% year-over-year to $2.5 billion; the trailing twelve-month figure through Mar 2026 stood at $2.5 billion (up 36.1% YoY), and the FY2025 full-year result was $2.1 billion, up 33.8% from the prior year.
• Equity Average for Q1 2026 stood at $2.5 billion, up from $2.5 billion in the prior quarter.
• Across five years, Equity Average topped out at $2.5 billion in Q1 2026 and bottomed at $966.2 million in Q3 2022.
• The 5-year median for Equity Average is $1.4 billion (2024), against an average of $1.6 billion.
• The widest annual swing landed in 2022, when Equity Average declined 8.2%; it then surged 46.59% in 2024.
• A 5-year view of Equity Average shows it stood at $1.0 billion in 2022, then gained by 26.43% to $1.3 billion in 2023, then jumped by 38.16% to $1.8 billion in 2024, then jumped by 35.43% to $2.5 billion in 2025, then gained by 0.72% to $2.5 billion in 2026.
• The last three Equity Average figures came in at $2.5 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.

Peer Comparison